CVS HEALTH CORPORATION Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-05: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-05: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-05: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-05: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-05 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-05 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-05 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-05 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-05-06 10-Q | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-06 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-06 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-06 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-04-03 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-03 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | Equity Grant Processes As discussed on page 52, the MP&D Committee follows a timeline for executive compensation decisions and approves and grants annual equity awards at approximately the same time every year so that compensation is appropriately aligned with the financial performance of th… | |
| 2026-04-03 DEF 14A | Award Timing Method | 2025-01-01..2025-12-31 | Equity awards, including options and SARs, are not granted in anticipation of the release of material non-public information, and the release of material non-public information is not timed on the basis of option or equity grant dates. In addition, we generally do not grant stock options or SARs (i)… | |
| 2026-04-03 DEF 14A | Award Timing How MNPI Considered | 2025-01-01..2025-12-31 | Equity awards, including options and SARs, are not granted in anticipation of the release of material non-public information, and the release of material non-public information is not timed on the basis of option or equity grant dates. In addition, we generally do not grant stock options or SARs (i)… | |
| 2026-04-03 DEF 14A | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | No | |
| 2026-04-03 DEF 14A | Award Timing Predetermined | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-03 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2025-01-01..2025-12-31 | No | |
| 2026-04-03 DEF 14A | Pay versus Performance Table | 2025-01-01..2025-12-31 | Pay Versus Performance As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, and Item 402(v) of Regulation S-K, we are providing the following information regarding the relationship between compensation actually paid (“CAP”) to our principal executiv… | |
| 2026-04-03 DEF 14A | Additional402v Disclosure | 2025-01-01..2025-12-31 | As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, and Item 402(v) of Regulation S-K, we are providing the following information regarding the relationship between compensation actually paid (“CAP”) to our principal executive officer (“PEO”) and N… | |
| 2026-04-03 DEF 14A | PEO Total Compensation | Individual: KarenSLynch | 2024-01-01..2024-10-17 | $23.43M |
| 2026-04-03 DEF 14A | PEO Actually Paid Compensation | Individual: KarenSLynch | 2024-01-01..2024-10-17 | -$15.06M |
| 2026-04-03 DEF 14A | PEO Total Compensation | Individual: LarryJMerlo | 2021-01-01..2021-01-31 | $3.78M |
| 2026-04-03 DEF 14A | PEO Actually Paid Compensation | Individual: LarryJMerlo | 2021-01-01..2021-01-31 | $52.82M |
| 2026-04-03 DEF 14A | Named Executive Officers Footnote | 2025-01-01..2025-12-31 | (1) First PEO refers to J. David Joyner , our current PEO, who became our PEO on October 17, 2024. Second PEO refers to Karen S. Lynch who was our PEO during the period from February 1, 2021 to October 17, 2024. Third PEO refers to Larry J. Merlo who was our PEO during the relevant period from Janua… | |
| 2026-04-03 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-01-01..2025-12-31 | Year Summary Compensation Table Total for First PEO ($) Exclusion of Change in Pension Value for First PEO ($) Exclusion of Stock Awards and Option Awards for First PEO ($) Inclusion of Pension Service Cost for First PEO ($) Inclusion of Equity Values for First PEO ($) Compensation Actually Paid to … | |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | -$64.64K |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | -$14.50M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: AggtPnsnAdjsSvcCst; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $43.83M |
| 2026-04-03 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-01-01..2025-12-31 | Year Average Summary Compensation Table Total for Non-PEO NEOs ($) Average Exclusion of Change in Pension Value for Non-PEO NEOs ($) Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs ($) Average Inclusion of Pension Service Cost for Non-PEO NEOs ($) Average Inclusion of Equity Val… | |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$619.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$7.15M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: AggtPnsnAdjsSvcCst; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $14.04M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $17.22M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $18.40M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $8.22M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo; Individual: JDavidJoyner | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $7.80M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $4.42M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $1.82M |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-03 DEF 14A | Peer Group Issuers Footnote | 2025-01-01..2025-12-31 | The Peer Group TSR set forth in this table utilizes the S&P 500 Health Care Sector Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended December 31, 2025. | |
| 2026-04-03 DEF 14A | Non Gaap Measure Description | Measure: 1 | 2025-01-01..2025-12-31 | The Company has determined that Adjusted EPS is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link CAP to the Company’s NEOs, for the most rec… |
| 2026-04-03 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2025-01-01..2025-12-31 | 1. CAP versus Company TSR and Peer Group TSR The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs, Company TSR and Peer Group TSR for the applicable reporting year. PEOs and Average Non-PEO NEO CAP Versus CVS Health Corporation TSR and Peer Group TSR | |
| 2026-04-03 DEF 14A | Total Shareholder Return Vs Peer Group | 2025-01-01..2025-12-31 | 1. CAP versus Company TSR and Peer Group TSR The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs, Company TSR and Peer Group TSR for the applicable reporting year. PEOs and Average Non-PEO NEO CAP Versus CVS Health Corporation TSR and Peer Group TSR | |
| 2026-04-03 DEF 14A | Compensation Actually Paid Vs Net Income | 2025-01-01..2025-12-31 | 2. CAP versus Net Income The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs and the Company’s GAAP Net Income for the applicable reporting year. PEOs and Average Non-PEO NEO CAP Versus Net Income | |
| 2026-04-03 DEF 14A | Compensation Actually Paid Vs Company Selected Measure | 2025-01-01..2025-12-31 | 3. CAP versus Adjusted EPS* The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs and Adjusted EPS* for the applicable reporting year. PEOs and Average Non-PEO NEO CAP Versus Adjusted EPS* | |
| 2026-04-03 DEF 14A | Tabular List Table | 2025-01-01..2025-12-31 | Most Important Measures to Determine FY2025 CAP The Company’s executive compensation program supports our long-term strategy by tying the vast majority of pay for executives to performance-based compensation. The three items listed below represent an unranked list of the most important performance m… | |
| 2026-02-10 10-K | Non Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-02-10 10-K | Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-02-10 10-K | Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-02-10 10-K | Non Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-02-10 10-K | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |